BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues

February 9, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced a turnover of of €7.5 million for 2009.

Twitter
LinkedIn
Facebook
Email
Print

Earnings Europe